AMERICAN SKIN ASSOCIATION ANNUAL GALA CELEBRATES OUTSTANDING HONOREES

Gala honors Renowned Surgeon Jesse M. Lewin, MD, FAAD, FACS and Global Pharmaceutical Leader Sanofi

NEW YORK, Sept. 11, 2025 /PRNewswire/ -- On Wednesday evening, at The Plaza Hotel, American Skin Association (ASA) held their Annual Gala. They presented awards to two outstanding honorees and celebrated another successful year of funding research and educating youth on skin health. The gala was attended by over 300 of ASA's loyal supporters and donors, including philanthropists, business leaders, and renowned physicians from the field of dermatology.

This year, awards were presented:

Jesse M. Lewin, MD, FAAD, FACS, Chief of Mohs Micrographic and Dermatologic Surgery, Vice Chair of Surgical Operations, Director of the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center, Fellowship Director - Micrographic Surgery and Dermatologic Oncology Fellowship, and Associate Professor of Dermatology at Icahn School of Medicine at Mount Sinai and The Kimberly and Eric J. Waldman Department of Dermatology, was presented ASA's Clinical Excellence in Melanoma and Skin Cancer Award for his tireless work towards discovering new dermatological therapies which bring hope to patients.

The award was presented by Mark G. Lebwohl, MD who praised Dr. Lewin's continued dedication to Dermatologic Surgery, his care for patients, and his mentorship of the next generation of dermatologic surgeons.

Global pharmaceutical leader, Sanofi, received ASA's 2025 Corporate Leadership Award. The award was presented by Emma Guttman-Yassky, MD, PhD and was accepted by Sanofi's Shaju Backer, Senior Vice President, Global Head of Immunology and Paul Rowe, MD, Senior Vice President, Head of Medical, Sanofi Specialty Care.

Sanofi is one of the world's leading healthcare companies – an R&D driven, AI-powered biopharma company committed to improving people's lives and creating compelling growth. Sanofi's mission is to chase the miracles of science to improve people's lives by discovering, developing, and delivering innovative medicines and vaccines for millions around the world.

Howard P. Milstein, Chairman of ASA, said, "ASA is proud to present Dr. Jesse Lewin and Sanofi these much-deserved awards for their dedication to the field of dermatology. Both Dr. Lewin and Sanofi share in our mission and we look forward to continuing to partner as we work towards finding cures for skin diseases."

For nearly four decades, ASA and its affiliates have funded over $50 million in grants to support the work of more than 300 promising young scientists. Recipients, who work on breakthrough efforts to prevent, detect, and treat skin cancer and other skin diseases, have gone on to become top researchers in dermatology. The critical research funded by ASA addresses not only the causes and treatments of melanoma, vitiligo, psoriasis, atopic dermatitis, and other skin diseases, but also promises remarkable breakthroughs in the search for long-sought-after cures. 

"I congratulate Dr. Jesse Lewin and Sanofi on their honors this evening. We look forward to continuing our long-standing work with physicians like Dr. Lewin and organizations like Sanofi as we work together to provide hope to patients and their families," said President of ASA, Dr. James G. Krueger.

ASA's educational mission is no less crucial. The organization continues to support the SPOTS (Sun Protection Outreach Teaching by Students) program, a free community outreach program designed to teach students from preschool through high school about the importance of early detection and prevention of skin cancer. ASA's educational contributions are part of a growing worldwide understanding of the importance of skin health awareness.

The event's Master of Ceremonies was NBC's Emmy-winning weather anchor Dave Price. Mr. Price has emceed the event in previous years and was once again a wonderful addition to the festivities.

ABOUT AMERICAN SKIN ASSOCIATION

A unique collaboration of patients, families, advocates, physicians, and scientists, ASA has evolved over nearly four decades as a leading force in efforts to defeat melanoma, vitiligo, psoriasis, atopic dermatitis, and other skin diseases. Established to serve the now more than 100 million Americans — one-third of the U.S. population — afflicted with skin disorders, the organization's mission remains to: advance research, champion skin health, particularly among children, and drive public awareness about skin disease. ASA is a 501(c)3 non-profit organization. For more information, visit americanskin.org.

American Skin Association has earned Candid's 2025 Seal of Platinum Transparency and the Four-Star Rating from Charity Navigator.

SOURCE American Skin Association